Product Information

PYRIDOSTIGMINE BR 60 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.2649 per EA under NDC 00115351101. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Apr 24, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PYRIDOSTIGMINE BR 60 MG TABLET

PYRIDOSTIGMINE BROMIDE
$0.2649per EA

Strength

60 mg/1

NDC

00115351101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PYRIDOSTIGMINE BROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA040502

FDA Approved

4/24/2003

TE Code

AB

On Market Since

4/24/2003

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.2649 per EA
All-time high$0.6549 (Oct 14, 2015)
All-time low$0.1867 (Nov 20, 2024)
52-week high$0.2753
52-week low$0.2558
Median price$0.3386
Average price$0.3626
Largest weekly change+52.5% (Apr 22, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-1.8%

1M

-1.8%

3M

-2.1%

6M

-1.7%

1Y

+3.6%

3Y

+13.0%

5Y

-27.0%

All

+0.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PYRIDOSTIGMINE BROMIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PYRIDOSTIGMINE BR 60 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE BR 60 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.2649 per EA (NDC 00115351101), effective Aug 19, 2026.

How has the price of PYRIDOSTIGMINE BR 60 MG TABLET changed over time?

Over the history we have for it, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has held within roughly two percent of its current level. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE BR 60 MG TABLET?

Since Nov 28, 2013, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has ranged from a low of $0.1867 (Nov 20, 2024) to a high of $0.6549 (Oct 14, 2015), with a median of $0.3386 per EA.

Are there cheaper alternatives to PYRIDOSTIGMINE BR 60 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PYRIDOSTIGMINE BR 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PYRIDOSTIGMINE BR 60 MG TABLET?

PYRIDOSTIGMINE BR 60 MG TABLET (NDC 00115351101) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.